Natixis Nuvasive Inc Transaction History

Natixis

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$36.71 - $44.15 $2.81 Million - $3.38 Million	-76,625 Reduced 28.93%	188,209 $7.83 Million
Q1 2023 May 12, 2023	BUY	$36.81 - $48.12 $9.69 Million - $12.7 Million	263,174 Added 15853.86%	264,834 $10.9 Million
Q4 2022 Feb 24, 2023	BUY	$35.68 - $44.71 $59,228 - $74,218	1,660 New	1,660 $68,000
Q4 2019 Feb 14, 2020	SELL	$60.96 - $77.7 $455,127 - $580,108	-7,466 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$55.78 - $68.08 $942,849 - $1.15 Million	-16,903 Reduced 69.36%	7,466 $473,000

Q2 2019 Aug 13, 2019	BUY	$53.69 - $65.47 $1.31 Million - $1.6 Million	24,369 New	24,369 $1.43 Million
Q2 2018 Aug 14, 2018	SELL	$48.15 - $56.68 $194,622 - $229,100	-4,042 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$46.03 - $61.28 $3,912 - $5,208	-85 Reduced 2.06%	4,042 $211,000
Q4 2017 Feb 14, 2018	SELL	$50.58 - $60.79 $864,968 - $1.04 Million	-17,101 Reduced 80.56%	4,127 $241,000
Q3 2017 Nov 14, 2017	BUY	$53.54 - $68.0 $1.14 Million - $1.44 Million	21,228	21,228 $1.18 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.